Resolute Capital Asset Partners LLC

Position in ORKA — Oruka Therapeutics, Inc.

CIK 1834913 DENVER, CO

Position in ORKA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$613,125

+$234,250 QoQ

Shares Held

12,500

0.0% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Resolute Capital Asset Partners LLC holds $27,245,478 across 4 Biotechnology names. ORKA ranks #3 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	98,627	$22,558,953
2	KOD	Kodiak Sciences Inc.	100,000	$3,812,000
3	ORKA	Oruka Therapeutics, Inc. This page	12,500	$613,125
4	SPRB	Spruce Biosciences, Inc.	4,000	$261,400

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$613,125	12,500	0.0%	Shares	Sole	2026-05-15
2025-12-31	$378,875	12,500	-83.3%	Shares	Sole	2026-02-17
2025-09-30	$1,442,250	75,000	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.